ADATTO MICHAEL 4
4 · HORIZON PHARMA, INC. · Filed Jan 3, 2013
Insider Transaction Report
Form 4
ADATTO MICHAEL
SVP, Sales & Managed Care
Transactions
- Award
Common Stock
2012-12-31+22,500→ 29,909 total - Award
Employee stock options (right to buy)
2013-01-02+21,750→ 21,750 totalExercise: $2.40Exp: 2023-01-01→ common stock (21,750 underlying) - Award
Restricted stock units
2013-01-02+19,800→ 19,800 total→ common stock (19,800 underlying) - Sale
Common stock
2013-01-02$2.36/sh−6,998$16,515→ 22,911 total
Footnotes (6)
- [F1]On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction.
- [F2]Includes 2,910 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
- [F3]Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
- [F4]The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
- [F6]The restricted stock units vest in four equal annual installments beginning January 2, 2014.